Top Markets
Coin of the day
AVAX Technologies, Inc. AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXT
Rank in Stocks #41955
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on... AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.
Share Price
$0.00001
Last synced: 2025-12-30
Market Cap
$6.89K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade AVAX Technologies, Inc. (AVXT)

Category

Stock split history for AVAX Technologies, Inc. (AVXT)
AVAX Technologies, Inc. stock (symbol: AVXT) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 13, 2026.
One AVXT share bought prior to Aug 13, 2026 would equal to 0 AVXT shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR